Learning objectives

After watching this webinar, participants will: 

• understand how to organise cancer treatment monitoring based on CV toxicity risks and the type of cancer therapies; and
• how to organise long-term cardiovascular surveillance.

Needs assessments

To describe through clinical cases how to implement into daily practice the 2022 recommendations of the ESC Guidelines on Cardio-Oncology.

Main Topic

• Cardiovascular disease in Special Populations

Related topic

• heart failure;
• ischemic heart disease; and
• metabolic syndrome.

Session information

This webinar is designed for healthcare professionals having an interest in heart failure and wishing to update their scientific knowledge on the topic.

During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.

Looking for more essentials on the New ESC Guidelines on Cardio Oncology? Watch the ESC 2022 Clinical Practice Guidelines Series on Cardio Oncology webinar on-demand here

• What we need to know before cancer therapy
• Who needs cardiovascular surveillance after cancer treatment?
• How to manage cancer therapy-related cardiovascular toxicity
• How to organise cardiovascular monitoring during cancer treatment: who, when and how

Technical settings

The webinar is available on PC and tablets. The use of a smartphone is not recommended.

To answer the MCQs during the live, you must allow pop-up windows.

A high-speed Internet connection is required (minimum 2 Mbps).